Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy

Chinekwu Anyanwu1, Gholam K Motamedi2

  • 1Department of Neurology, Virginia Tech Carilion School of Medicine, Roanoke, VA 24016, USA. nekwusky@gmail.com.

Brain Sciences
|March 22, 2018
PubMed

Insights

For drug-resistant epilepsy, surgery can be curative. This review details the complex presurgical evaluation needed to identify the seizure onset zone and ensure surgical safety for patients with focal onset epilepsy.

Area of Science:

  • Neurology
  • Neurosurgery
  • Epileptology

Background:

  • Approximately one-third of epilepsy patients experience drug-resistant seizures despite trials of multiple antiepileptic drugs.
  • Epilepsy surgery presents a curative option for individuals with focal onset drug-resistant epilepsy.
  • Underutilization of epilepsy surgery may stem from the intricate nature of presurgical evaluation.

Purpose of the Study:

  • To review the comprehensive presurgical evaluation process for patients with drug-resistant focal onset epilepsy.
  • To outline the key steps involved in preparing patients for epilepsy surgery.

Main Methods:

  • Review of the established protocols and diagnostic procedures for epilepsy presurgical evaluation.
  • Discussion of tests required for seizure classification, lateralization, and localization of the epileptogenic zone.
  • Emphasis on neurocognitive assessments to ensure surgical safety regarding language and memory functions.

Main Results:

  • The presurgical evaluation is a multi-step process essential for successful epilepsy surgery.
  • Accurate classification of seizure type, precise localization of the seizure onset focus, and assessment of potential neurocognitive deficits are critical.
  • Each diagnostic step necessitates specialized testing to inform surgical planning.

Conclusions:

  • A thorough presurgical evaluation is paramount for optimizing outcomes in epilepsy surgery.
  • Understanding and navigating the complexity of presurgical assessment can help increase the utilization of epilepsy surgery for intractable epilepsy.
  • This review provides a framework for the systematic evaluation of patients with drug-resistant focal epilepsy.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
878
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
537
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
736
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
523
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K